Mobile Cardiac Telemetry Market Global Report 2026

The mobile cardiac telemetry market size has grown strongly in recent years. It will grow from $1.67 billion in 2025 to $1.83 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases and cardiac arrhythmias, rising demand for remote cardiac monitoring solutions, growing adoption of ambulatory healthcare services, expanding elderly population requiring continuous heart monitoring, increasing healthcare provider focus on early detection of cardiac abnormalities.

The mobile cardiac telemetry market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising adoption of home-based cardiac monitoring services, increasing demand for real-time cardiac event detection, growing integration of advanced wearable sensors in cardiac monitoring devices, expanding use of remote patient monitoring platforms, increasing investment in decentralized and value-based cardiac care models. Major trends in the forecast period include increasing adoption of wearable cardiac monitoring patches for continuous remote heart rhythm tracking, growing demand for real-time arrhythmia detection and prolonged cardiac monitoring solutions, rising deployment of cellular-enabled mobile cardiac telemetry systems for remote patient monitoring, increasing preference for non-invasive ambulatory cardiac monitoring over traditional diagnostic methods, growing focus on compact and patient-friendly cardiac monitoring devices for home-based care.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the mobile cardiac telemetry market going forward. Cardiovascular diseases are a group of conditions that impact the heart and blood vessels, including coronary artery disease, heart failure, stroke, and cardiac arrhythmias. The prevalence of cardiovascular diseases is increasing due to aging populations, sedentary lifestyles, rising obesity levels, and the growing occurrence of diabetes and hypertension, which continue to expand the number of individuals requiring long-term cardiac monitoring and care. As the burden of cardiovascular diseases rises, the demand for mobile cardiac telemetry is increasing due to its ability to provide continuous remote ECG monitoring, enable early detection of arrhythmias, facilitate timely clinical intervention, and improve long-term cardiac care. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, 919,032 people died from cardiovascular disease in the United States in 2023, representing 1 in every 3 deaths, while one person died from cardiovascular disease every 34 seconds. Therefore, the increasing prevalence of cardiovascular diseases is supporting the growth of the mobile cardiac telemetry market.

Leading companies operating in the mobile cardiac telemetry market are focusing on developing advanced solutions, including integrated ambulatory cardiac monitoring solutions, to enhance remote cardiac diagnostics and clinical workflow efficiency. Ambulatory cardiac monitoring solutions are wearable diagnostic systems that continuously capture a patient’s heart activity during regular daily activities outside a clinical environment, supporting the early identification of cardiac rhythm abnormalities and enabling timely clinical intervention. For example, in May 2024, VivaLNK Inc., a US-based biometric technology company, launched its Turnkey Ambulatory Cardiac Monitoring Solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution combines VivaLNK's wearable electrocardiogram (ECG) sensor technology with a cloud-based platform, real-time data transmission capabilities, and clinical workflow functionalities, enabling healthcare providers and diagnostic service organizations to deliver scalable remote cardiac monitoring solutions.

In December 2024, SmartCardia SA, a Switzerland-based manufacturer of wearable ECG monitoring devices and mobile cardiac telemetry solutions, acquired Cardiomedix Inc. for an undisclosed value. Through this acquisition, SmartCardia aims to broaden its end-to-end mobile cardiac telemetry and remote cardiac monitoring services across the United States by combining wearable ECG technology with an integrated diagnostic platform. Cardiomedix Inc. is a US-based company specializing in ambulatory cardiac monitoring services, including mobile cardiac telemetry and remote cardiac diagnostic solutions for identifying and managing cardiac arrhythmias.

Major companies operating in the mobile cardiac telemetry market report are iRhythm Technologies Inc., Philips, Medtronic plc, Abbott Laboratories, AliveCor Inc., Fukuda Denshi Co. Ltd., VitalConnect Inc., ScottCare Corporation, Medicalgorithmics S.A., Bittium Corp., Vivalink, Biotricity Inc., Schiller AG, ACS Diagnostics (Applied Cardiac Systems), InfoBionic.ai, Qardio Inc., SmartCardia SA, Aerotel Medical Systems Ltd., Norav Medical Ltd., CardiacSense Ltd., Vector Remote Care LLC, Myocardial Solutions Inc.

North America was the dominant region in the mobile cardiac telemetry market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the mobile cardiac telemetry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mobile cardiac telemetry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.